CorMedix Inc.

CRMD

$5.30

Name : CorMedix Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $421,229,120.00

EPSttm : 2.05

CorMedix Inc.

$5.30

1.30%

$0.07

CRMD — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

19.87

Margin Of Safety %

Put/Call OI Ratio

0.77

EPS Next Q Diff

-0.42

EPS Last/This Y

-1.76

EPS This/Next Y

-0.48

Price

5.31

Target Price

15.2

Analyst Recom

Performance Q

-34.89

Upside

408.4%

Beta

1.49

Ticker: CRMD

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	CRMD	7.45	0.93	0.12	32934
2026-10-13	CRMD	7.4	0.91	3.50	33331
2026-10-14	CRMD	7.4	0.93	0.11	33845
2026-10-15	CRMD	7.46	0.93	2.35	33735
2026-10-16	CRMD	7.28	0.93	0.05	33899
2026-10-19	CRMD	7.38	0.97	0.16	32881
2026-10-20	CRMD	7.57	0.95	0.74	33264
2026-10-21	CRMD	7.8	0.95	0.52	33597
2026-10-22	CRMD	8.1	0.94	0.07	34370
2026-10-23	CRMD	7.84	0.93	0.16	34610
2026-10-26	CRMD	7.95	0.92	0.25	34736
2026-10-27	CRMD	8.01	0.92	4.47	34877
2026-10-28	CRMD	8.21	0.92	0.00	35003
2026-10-29	CRMD	7.64	0.88	1.51	35791
2026-10-30	CRMD	5.7	0.89	0.96	36385
2026-11-02	CRMD	5.39	0.87	0.72	37616
2026-11-03	CRMD	5.57	0.86	0.07	39139
2026-11-04	CRMD	5.65	0.84	0.53	39383
2026-11-05	CRMD	5.22	0.83	0.40	39842
2026-11-06	CRMD	5.32	0.83	0.08	39567
2026-11-09	CRMD	5.48	0.83	3.10	39580
2026-11-10	CRMD	5.36	0.77	0.50	38789
2026-11-11	CRMD	5.31	0.77	0.00	38979
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	CRMD	7.44	-	-	0.49
2026-10-13	CRMD	7.40	-	-	0.49
2026-10-14	CRMD	7.40	-	-	0.49
2026-10-15	CRMD	7.47	-	-	0.49
2026-10-16	CRMD	7.28	-	-	0.49
2026-10-19	CRMD	7.38	-	-	0.49
2026-10-20	CRMD	7.38	-	-	0.49
2026-10-21	CRMD	7.57	-	-	0.49
2026-10-22	CRMD	8.10	-	-	0.49
2026-10-23	CRMD	7.84	-	-	0.49
2026-10-26	CRMD	7.94	-	-	0.49
2026-10-27	CRMD	8.00	-	-	0.49
2026-10-28	CRMD	8.22	-	-	0.49
2026-10-29	CRMD	7.64	-	-	0.49
2026-10-30	CRMD	5.69	-	-	0.49
2026-11-02	CRMD	5.38	-	-	0.49
2026-11-03	CRMD	5.57	-	-	0.49
2026-11-04	CRMD	5.65	-	-	0.49
2026-11-05	CRMD	5.22	-	-	0.49
2026-11-06	CRMD	5.30	-	-	0.49
2026-11-09	CRMD	5.49	-	-	0.49
2026-11-10	CRMD	5.36	-	-	0.49
2026-11-11	CRMD	5.31	-	-	0.49
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	CRMD	0.00	3.03	21.58
2026-10-13	CRMD	0.00	3.03	21.58
2026-10-14	CRMD	0.00	3.03	21.58
2026-10-15	CRMD	0.00	3.03	21.58
2026-10-16	CRMD	0.00	3.03	21.58
2026-10-19	CRMD	0.00	2.70	21.58
2026-10-20	CRMD	0.00	2.70	21.58
2026-10-21	CRMD	0.00	2.70	21.58
2026-10-22	CRMD	0.00	2.70	21.58
2026-10-23	CRMD	0.00	2.70	21.58
2026-10-26	CRMD	0.00	2.70	21.58
2026-10-27	CRMD	0.00	2.70	20.52
2026-10-28	CRMD	0.00	2.70	20.52
2026-10-29	CRMD	0.00	2.70	20.52
2026-10-30	CRMD	0.00	2.70	20.52
2026-11-02	CRMD	0.00	2.72	20.52
2026-11-03	CRMD	0.00	2.72	20.52
2026-11-05	CRMD	0.00	2.72	20.52
2026-11-06	CRMD	0.00	2.72	20.52
2026-11-09	CRMD	0.00	2.79	20.52
2026-11-10	CRMD	0.00	2.79	20.52
2026-11-11	CRMD	0.00	2.79	19.87
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.29

Avg. EPS Est. Current Quarter

-0.11

Avg. EPS Est. Next Quarter

-0.13

Insider Transactions

Institutional Transactions

2.79

Beta

1.49

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

9.3

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

69.5

Max Drawdown 5-Year %

-68.4

Target Price

15.2

P/E

2.52

Forward P/E

69.74

PEG

P/S

0.89

P/B

0.89

P/Free Cash Flow

1.65

EPS

2.1

Average EPS Est. Cur. Y

0.49

EPS Next Y. (Est.)

0.01

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

40.49

Relative Volume

1.13

Return on Equity vs Sector %

14.2

Return on Equity vs Industry %

33.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ CRMD Healthcare

$5.30

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

13/25

Volume

1/15

Valuation

18/20

TP/AR

2/10

Options

3/10

RSI

28.8

Range 1M

4.8%

Sup Dist

1.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

10/25

Growth

11/30

Estimates

4/20

Inst/Vol

6/15

Options

7/10

EPS Yr

-76.9%

EPS NY

-83.9%

52W%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟡 HOLD +11.3% upside

Quality

30/30

Valuation

13/30

Growth

6/25

Stability

6/10

LT Trend

4/5

Upside

+11.3%

Quality

MoS

75%

CRMD — P/E HistoricalBiotechnology

CorMedix Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 191

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

CRMD

Latest News

—

Caricamento notizie per CRMD…

stock quote shares CRMD – CorMedix Inc. Stock Price stock today

news today CRMD – CorMedix Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CRMD – CorMedix Inc. yahoo finance google finance

stock history CRMD – CorMedix Inc. invest stock market

stock prices CRMD premarket after hours

ticker CRMD fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CRMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y